Enwei Pharmaceutical announced that the company's mid-term dividend payment plan for 2025 is based on the company's current total share capital of 103 million shares excluding 102 million shares after the repurchased shares, to all shareholders a cash dividend of RMB 3.5 million for every 10 shares. The actual total cash dividend will be distributed to all shareholders of RMB 35.642,800.

Enwei Pharmaceutical announced that the company's mid-term dividend payment plan for 2025 is based on the company's current total share capital of 103 million shares excluding 102 million shares after the repurchased shares, to all shareholders a cash dividend of RMB 3.5 million for every 10 shares. The actual total cash dividend will be distributed to all shareholders of RMB 35.642,800.